CRDF stock

Cardiff Oncology Inc (CRDF) financials · rev $593.0K

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Cardiff Oncology Inc (CRDF) rev $593.0K.

Cached annual income statement
LineFY2025FY2024
Revenue$593.0K$683.0K
Operating Income-$49.0M-$48.7M
Net Income-$45.9M-$45.4M
EPS (Diluted)-$0.69-$0.95
Cached annual balance sheet
LineFY2025FY2024
Total Assets$61.9M$97.2M
Current Assets$60.1M$95.1M
Cash & Equivalents$17.5M$51.5M
PP&E$578.0K$898.0K
Total Liabilities$16.5M$14.2M
Current Liabilities$16.4M$13.4M
Shareholders' Equity$45.4M$82.9M
Retained Earnings-$430.0M-$384.2M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$37.9M-$37.7M
CapEx$44.0K$80.0K
Investing Cash Flow$1.34M$13.7M
Financing Cash Flow$2.58M$53.8M
Net Change in Cash-$34.0M$29.8M
Free Cash Flow-$38.0M-$37.8M
These statements as JSON? API free 100/day

FAQ

What is CRDF P/E and revenue?

Cardiff Oncology Inc (CRDF) rev $593.0K.

What is CRDF revenue?

Cardiff Oncology Inc last cached revenue is $593.0K (FY2025).

Is CRDF profitable?

Cardiff Oncology Inc last cached net income is -$45.9M (FY2025).

What are CRDF total assets?

Cardiff Oncology Inc last cached total assets are $61.9M (FY2025).

What is CRDF free cash flow?

Cardiff Oncology Inc last cached free cash flow is -$38.0M (FY2025).

Not investment advice. Cached statements, not a live tape.